Evren Alici, MD, PhD: Founder; Chairman & CEO

• Head of Gene & Cell Therapy Group, Division of Hematology, Department of Medicine
  at the Karolinska Institutet (KI) & Karolinska University Hospital, Sweden
• Serves on Advisory Boards for Pfizer, Sanofi and Johnson & Johnson
• Founding Managing Director, NextGenNK at KI

David Adams: Independent Director

• Co-Founder of MintPharma Capital Investment Fund & Managing Partner of Mint12,
  a Specialized Alternative Investment Management Company

Douglas W. Calder: President & Executive Director

• 25+ Years of Senior Executive Biotech Experience for Public & Private Companies
• Member of Board of Directors for: NextGenNK, Swedish Innovation Agency’s NK Cell Competence Center
  at KI; Zevra Therapeutics (Nasdaq: ZVRA), and BioFlorida

Robert Finizio: Independent Director

• Managing Director/Co-Founder of MintPharma Capital Investment Fund; Co-Founder, CEO, Vice Chairman of TherapeuticsMD
  (Nasdaq: TXMD); Co-Founder of CareFusion (sold to Cardinal Health in 2006); Chairman of BioFlorida

HG Ljunggren, MD, PhD: Founder; Executive Director

• Professor, Former Dean of Research, & Founder of Center for Infectious Medicine at Karolinska Institutet (KI), Sweden
• Founding Managing Director, NextGenNK at KI
• Member of Nobel Assembly at KI

Jackson Streeter, MD: Independent Director

• Partner at DeepWork Capital; Director of Ventures at University of Florida; Recognized for
  Founding & Leading Multiple Life Science Ventures to Exits

Governor Tommy Thompson: Independent Director

• Former Secretary of US Health & Human Services (HHS); Former 4-term Governor of Wisconsin;
  Director at United Therapeutics (Nasdaq: UTHR) & at HealthPeak Properties (NYSE: DOC)